WallStreetZen

NASDAQ: ICPT
Intercept Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ICPT

Based on 7 analysts offering 12 month price targets for Intercept Pharmaceuticals Inc.
Min Forecast
$10.00-36.95%
Avg Forecast
$33.57+111.67%
Max Forecast
$88.00+454.85%

Should I buy or sell ICPT stock?

Based on 8 analysts offering ratings for Intercept Pharmaceuticals Inc.
Hold
Strong Buy
0 analysts 0%
Buy
3 analysts 37.5%
Hold
3 analysts 37.5%
Sell
1 analysts 12.5%
Strong Sell
1 analysts 12.5%

ICPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Top 16%
85
BuyMaintains$44.00+177.43%2021-11-04
Goldman Sachs
Top 11%
90
Strong SellDowngrades$10.00-36.95%2021-08-20
HC Wainwright & Co.
Bottom 4%
4
HoldMaintains$18.00+13.49%2021-08-02
RBC Capital
Top 20%
81
HoldMaintains$23.00+45.02%2021-07-30
B. Riley Securities
Top 1%
100
HoldDowngrades$18.00+13.49%2021-05-26
Anonymous
Goldman Sachs
HoldMaintains$18.00+13.49%2021-05-07
Needham
Bottom 10%
10
BuyMaintains$34.00+114.38%2021-03-02
Wedbush
Bottom 3%
3
BuyMaintains$88.00+454.85%2021-03-01
Bank of America
Bottom 7%
7
SellDowngradesN/AN/A2021-01-15

1 of 1

Forecast return on equity

Is ICPT forecast to generate an efficient return?
Company
-90.33%
Industry
21.88%
Market
37.5%
ICPT's Return on Equity is forecast to be low in 3 years (-90.33%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ICPT forecast to generate an efficient return on assets?
Company
26.94%
Industry
6.66%
ICPT is forecast to generate higher Return on Assets (26.94%) than the US Biotechnology industry average (6.66%)
Forecast

ICPT earnings per share forecast

What is ICPT's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
-$3.87+19.44%
Avg 2 year Forecast
-$4.22+30.25%
Avg 3 year Forecast
-$1.26-61.11%

ICPT revenue forecast

What is ICPT's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$363.0M+2.43%
Avg 2 year Forecast
$388.8M+9.72%
Avg 3 year Forecast
$513.3M+44.87%
ICPT's revenue is forecast to grow at a rate of 11.93% per year, which is not exceptional
Forecast

ICPT revenue growth forecast

How is ICPT forecast to perform vs Biotechnology companies and vs the US market?
Company
11.93%
Industry
30.03%
Market
10.08%
ICPT's revenues are forecast to grow slower (11.93% per year) than the US Biotechnology industry average (30.03%)
Forecast
ICPT's revenues are forecast to grow faster (11.93% per year) than the US market average (10.08%)
Forecast

Intercept Pharmaceuticals Stock Forecast FAQ

Is Intercept Pharmaceuticals Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: ICPT) stock is to Hold ICPT stock.

Out of 8 analysts, 0 (0%) are recommending ICPT as a Strong Buy, 3 (37.5%) are recommending ICPT as a Buy, 3 (37.5%) are recommending ICPT as a Hold, 1 (12.5%) are recommending ICPT as a Sell, and 1 (12.5%) are recommending ICPT as a Strong Sell.

What is ICPT's earnings growth forecast for 2021-2023?

(NASDAQ: ICPT) Intercept Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 6.78%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Intercept Pharmaceuticals's earnings in 2021 is -$107,293,000.On average, 9 Wall Street analysts forecast ICPT's earnings for 2021 to be $-114,346,789, with the lowest ICPT earnings forecast at $-145,075,642, and the highest ICPT earnings forecast at $-89,822,801. On average, 10 Wall Street analysts forecast ICPT's earnings for 2022 to be $-124,688,230, with the lowest ICPT earnings forecast at $-180,532,011, and the highest ICPT earnings forecast at $-81,845,118.

In 2023, ICPT is forecast to generate $-37,229,187 in earnings, with the lowest earnings forecast at $-159,553,660 and the highest earnings forecast at $232,534,685.

What is ICPT's revenue growth forecast for 2021-2023?

(NASDAQ: ICPT) Intercept Pharmaceuticals's forecast annual revenue growth rate of 11.93% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.03%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Intercept Pharmaceuticals's revenue in 2021 is $354,332,000.On average, 7 Wall Street analysts forecast ICPT's revenue for 2021 to be $10,724,133,307, with the lowest ICPT revenue forecast at $10,555,656,462, and the highest ICPT revenue forecast at $10,793,509,602. On average, 7 Wall Street analysts forecast ICPT's revenue for 2022 to be $11,487,361,193, with the lowest ICPT revenue forecast at $10,016,424,186, and the highest ICPT revenue forecast at $13,519,808,893.

In 2023, ICPT is forecast to generate $15,167,407,257 in revenue, with the lowest revenue forecast at $9,006,597,256 and the highest revenue forecast at $26,332,263,229.

What is ICPT's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: ICPT) forecast ROA is 26.94%, which is higher than the forecast US Biotechnology industry average of 6.66%.

What is ICPT's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ICPT price target, the average ICPT price target is $33.57, with the highest ICPT stock price forecast at $88.00 and the lowest ICPT stock price forecast at $10.00.

On average, Wall Street analysts predict that Intercept Pharmaceuticals's share price could stay at $33.57 by Nov 4, 2022. The average Intercept Pharmaceuticals stock price prediction forecasts a potential downside of N/A from the current ICPT share price of $15.86.

What is ICPT's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: ICPT) Intercept Pharmaceuticals's current Earnings Per Share (EPS) is -$3.24. On average, analysts forecast that ICPT's EPS will be $-3.87 for 2021, with the lowest EPS forecast at $-4.91, and the highest EPS forecast at $-3.04. On average, analysts forecast that ICPT's EPS will be $-4.22 for 2022, with the lowest EPS forecast at $-6.11, and the highest EPS forecast at $-2.77. In 2023, ICPT's EPS is forecast to hit $-1.26 (min: $-5.40, max: $7.87).

What is ICPT's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: ICPT) forecast ROE is -90.33%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.